Abstract

In this article I argue that Hegel has become analytic philosophy’s “pharmakon”—both its “poison” and its “cure.” Traditionally, Hegel’s philosophy has been attacked by Anglo-American analytical philosophers for its alleged charlatanism and irrelevance. Yet starting from the 1970s there has been a revival of interest in Hegel’s philosophical work, which, I suggest, may be explained by three developments: the revival of interest in Aristotelianism following Saul Kripke’s and Hilary Putnam’s work on natural kinds, and Elizabeth Anscombe’s, Philippa Foot’s, and Putnam’s opposition to the fact-value distinction; the rehabilitation of Hegel’s theories by various philosophers, including Robert Pippin, Terry Pinkard, Fred Beiser, Robert Stern, and Stephen Houlgate; and the Sellars-inspired philosophy of mind of John McDowell and of Robert Brandom. The first and third of these reasons, I argue, have led several analytic theorists to cast Hegel in a more positive light as the “cure” for analyti...